SDHB系统
医学
副神经节瘤
生殖系
基因型
种系突变
入射(几何)
人口
横断面研究
流行病学
内科学
儿科
病理
遗传学
突变
生物
光学
物理
环境卫生
基因
作者
Amanda Seabrook,Anand Vasudevan,Kristen Neville,Brigitte Gerstl,Diana E. Benn,Janine Smith,Judy Kirk,Anthony J. Gill,Roderick Clifton‐Bligh,Katherine Tucker
标识
DOI:10.1136/archdischild-2023-325419
摘要
Phaeochromocytoma (PC) and paraganglioma (PGL) syndromes associated with germline pathogenic variants are associated with high morbidity and mortality. Establishing genotype–phenotype correlations within a young population is challenging due to their rare occurrence. Objective To describe genotype–phenotype correlations in paediatric and adolescent patients diagnosed with PC/PGL. To establish the incidence of PC/PGL in a young population and prevalence of germline pathogenic variants within this group. Study design We conducted a cross-sectional study of patients diagnosed with a PC/PGL aged 0–21 years old who were reviewed within Familial Cancer Services within New South Wales and the Australian Capital Territory, Australia. Results A germline pathogenic variant was detected in 80% (24/30) of patients; SDHB : n=12, VHL : n=11, and MAX : n=1. Only patients harbouring a germline pathogenic variant reported a family history of syndromic tumours, those with apparently sporadic disease did not (62.5% versus 0%, p=0.02). All patients with VHL presented with an adrenal tumour compared with 25% of those with SDHB (100% versus 25%, p=0.01). Occurrence of multiple primary PC/PGL was seen in patients with VHL however was absent in patients with SDHB (36% versus 0%, p=0.03). Incidence rate of paediatric PC/PGL was 0.45 cases per million person years. Conclusions PC/PGL diagnosed in children and adolescents were strongly associated with germline pathogenic variants in VHL or SDHB . These patients should be referred to specialist services for family counselling and genetic testing along followed by investigations for the detection of bilateral, multifocal or metastatic disease, and lifelong surveillance for recurrent disease.
科研通智能强力驱动
Strongly Powered by AbleSci AI